Warning! GuruFocus detected
1 Severe warning sign
with RNTX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Rein Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US00887A1051
Description
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 367.75 | |||||
| Equity-to-Asset | 0.48 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 34.3 | |||||
| 3-Year EPS without NRI Growth Rate | 35.7 | |||||
| 3-Year FCF Growth Rate | 28.4 | |||||
| 3-Year Book Growth Rate | -36.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 18.07 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.22 | |||||
| 9-Day RSI | 35.14 | |||||
| 14-Day RSI | 38.45 | |||||
| 3-1 Month Momentum % | -16.67 | |||||
| 6-1 Month Momentum % | -45.09 | |||||
| 12-1 Month Momentum % | -67.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | |||||
| Quick Ratio | 3.3 | |||||
| Cash Ratio | 3.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.7 | |||||
| Shareholder Yield % | -0.04 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -86.47 | |||||
| ROA % | -33.87 | |||||
| ROIC % | -42.69 | |||||
| 3-Year ROIIC % | 5.88 | |||||
| ROC (Joel Greenblatt) % | -259798.25 | |||||
| ROCE % | -36.07 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.73 | |||||
| EV-to-EBIT | -0.64 | |||||
| EV-to-EBITDA | -0.64 | |||||
| EV-to-FCF | -0.68 | |||||
| Earnings Yield (Greenblatt) % | -156.25 | |||||
| FCF Yield % | -75.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RNTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rein Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.15 | ||
| Beta | 1.76 | ||
| 3-Year Sharpe Ratio | -0.09 | ||
| 3-Year Sortino Ratio | -0.14 | ||
| Volatility % | 78.11 | ||
| 14-Day RSI | 38.45 | ||
| 14-Day ATR ($) | 0.19756 | ||
| 20-Day SMA ($) | 1.869 | ||
| 12-1 Month Momentum % | -67.47 | ||
| 52-Week Range ($) | 1.5023 - 7.42 | ||
| Shares Outstanding (Mil) | 21.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rein Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rein Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rein Therapeutics Inc Frequently Asked Questions
What is Rein Therapeutics Inc(RNTX)'s stock price today?
The current price of RNTX is $1.70. The 52 week high of RNTX is $7.42 and 52 week low is $1.50.
When is next earnings date of Rein Therapeutics Inc(RNTX)?
The next earnings date of Rein Therapeutics Inc(RNTX) is 2025-04-15 Est..
Does Rein Therapeutics Inc(RNTX) pay dividends? If so, how much?
Rein Therapeutics Inc(RNTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers